These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11162550)
21. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH. Kwak HB; Lee SW; Li YJ; Kim YA; Han SY; Jhon GJ; Kim HH; Lee ZH Biochem Pharmacol; 2004 Apr; 67(7):1239-48. PubMed ID: 15013839 [TBL] [Abstract][Full Text] [Related]
22. Regulation of osteoclastogenesis by gap junction communication. Matemba SF; Lie A; Ransjö M J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710 [TBL] [Abstract][Full Text] [Related]
23. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Uchiyama S; Yamaguchi M Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845 [TBL] [Abstract][Full Text] [Related]
26. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Miyamoto T; Arai F; Ohneda O; Takagi K; Anderson DM; Suda T Blood; 2000 Dec; 96(13):4335-43. PubMed ID: 11110710 [TBL] [Abstract][Full Text] [Related]
27. Osteoclast development from hematopoietic stem cells: apparent divergence of the osteoclast lineage prior to macrophage commitment. Hayase Y; Muguruma Y; Lee MY Exp Hematol; 1997 Jan; 25(1):19-25. PubMed ID: 8989902 [TBL] [Abstract][Full Text] [Related]